These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2703135)
1. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer]. Kaufmann M; Klinga K; Kühn W; Abel U Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135 [TBL] [Abstract][Full Text] [Related]
2. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer]. Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019 [TBL] [Abstract][Full Text] [Related]
3. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer]. Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702 [TBL] [Abstract][Full Text] [Related]
4. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma]. Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147 [TBL] [Abstract][Full Text] [Related]
5. [Follow-up of 551 patients with node-negative breast cancer]. Eidtmann H; Jonat W; Lange C; Friedrichs K; Maass H Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):454-61. PubMed ID: 1397940 [TBL] [Abstract][Full Text] [Related]
6. Survival of women with node negative breast cancer in the Auckland region. Lethaby AE; Mason BH; Harvey VJ; Holdaway IM N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512 [TBL] [Abstract][Full Text] [Related]
8. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
10. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in medullary breast cancer]. Mitze M; Goepel E Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051 [TBL] [Abstract][Full Text] [Related]
13. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast. Friedman NS; Freedman MD Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198 [TBL] [Abstract][Full Text] [Related]
14. [Cathepsin D in primary breast cancer in correlation with various prognostic factors]. Rempen A; Caffier H Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323 [TBL] [Abstract][Full Text] [Related]
15. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands]. Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143 [TBL] [Abstract][Full Text] [Related]
16. [The prognostic significance of cathepsin D in primary breast cancer]. Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750 [TBL] [Abstract][Full Text] [Related]
17. Testosterone and biological characteristics of breast cancers in postmenopausal women. Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675 [TBL] [Abstract][Full Text] [Related]
18. Primary tumour characteristics and axillary lymph node status in breast cancer. Yiangou C; Shousha S; Sinnett HD Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048 [TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer. Bolwell B; Andresen S; Pohlman B; Sobecks R; Goormastic M; Rybicki L; Bell K; Kalaycio M Bone Marrow Transplant; 2001 Apr; 27(8):843-6. PubMed ID: 11477442 [TBL] [Abstract][Full Text] [Related]
20. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]